The lawsuit against Gilead alleges that a "nogeneric" component scheme kept HIV drugs at the skyhigh levels even though generic versions are available. httpsbuff.ly2VDDx1tÂ

The lawsuit against Gilead alleges that a "no-generic" component scheme kept #HIV drugs at the “sky-high” levels, even though generic versions are available. https://buff.ly/2VDDx1t

20:00 EDT 14 May 2019 | STAT

The lawsuit against Gilead alleges that a "no-generic" component scheme kept #HIV drugs at the “sky-high” levels, even though generic versions are available. https://buff.ly/2VDDx1t

More From BioPortfolio on "The lawsuit against Gilead alleges that a "no-generic" component scheme kept #HIV drugs at the “sky-high” levels, even though generic versions are available. https://buff.ly/2VDDx1t "